Please assess the completion status of the following clinical trial:

Trial Title: XprESS Eustachian Tube Dilation Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ≥18 years old~* Have been diagnosed with symptoms of chronic Eustachian tube dysfunction for no less than 12 months prior to enrollment~* Have an overall ETDQ-7 score ≥3.0~* Have record of failed medical management for Eustachian tube dysfunction~Exclusion Criteria:~* Require concomitant procedures at the time of the study enrollment or procedure~* Have patulous Eustachian tube~* Have ear tubes in place or perforation of the tympanic membrane~* Have evidence of internal carotid artery dehiscence~* Be pregnant at the time of enrollment~* Be currently participating in other drug or device studies

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- XprESS (Type: EXPERIMENTAL): Balloon dilation of the Eustachian tube
- Control (Type: OTHER): Continued medical management

Based on this trial design, predict the completion outcome and termination type (if applicable).